Acorah Software Products - Accounts Production 16.4.675 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 9503180 Dr ONYEMAECHI ABAZIE Mrs JUSTINA ABAZIE Dr Onyemaechi Abazie true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 9503180 2024-03-31 9503180 2025-03-31 9503180 2024-04-01 2025-03-31 9503180 frs-core:CurrentFinancialInstruments 2025-03-31 9503180 frs-core:ComputerEquipment 2025-03-31 9503180 frs-core:ComputerEquipment 2024-04-01 2025-03-31 9503180 frs-core:ComputerEquipment 2024-03-31 9503180 frs-core:ShareCapital 2025-03-31 9503180 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 9503180 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 9503180 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 9503180 frs-bus:SmallEntities 2024-04-01 2025-03-31 9503180 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 9503180 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 9503180 frs-bus:OrdinaryShareClass1 2024-04-01 2025-03-31 9503180 frs-bus:OrdinaryShareClass1 2025-03-31 9503180 1 2024-04-01 2025-03-31 9503180 frs-bus:Director1 2024-04-01 2025-03-31 9503180 frs-bus:Director2 2024-04-01 2025-03-31 9503180 frs-countries:EnglandWales 2024-04-01 2025-03-31 9503180 2023-03-31 9503180 2024-03-31 9503180 2023-04-01 2024-03-31 9503180 frs-core:CurrentFinancialInstruments 2024-03-31 9503180 frs-core:ShareCapital 2024-03-31 9503180 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 9503180 frs-bus:OrdinaryShareClass1 2023-04-01 2024-03-31
Registered number: 9503180
CHIEDA MEDICAL CONSULTING LIMITED
Financial Statements
For The Year Ended 31 March 2025
TOCKAN & CO
CHARTERED CERTIFIED ACCOUNTANTS
30 HEDDON COURT
COCKFOSTERS ROAD
LONDON
EN4 0DF
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—3
Page 1
Balance Sheet
Registered number: 9503180
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 - 1,352
- 1,352
CURRENT ASSETS
Cash at bank and in hand 14,489 9,765
14,489 9,765
Creditors: Amounts Falling Due Within One Year 5 (4,145 ) (3,481 )
NET CURRENT ASSETS (LIABILITIES) 10,344 6,284
TOTAL ASSETS LESS CURRENT LIABILITIES 10,344 7,636
NET ASSETS 10,344 7,636
CAPITAL AND RESERVES
Called up share capital 6 2 2
Profit and Loss Account 10,342 7,634
SHAREHOLDERS' FUNDS 10,344 7,636
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr ONYEMAECHI ABAZIE
Director
29/08/2025
The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
CHIEDA MEDICAL CONSULTING LIMITED Registered number 9503180 is a limited by shares company incorporated in England & Wales. The Registered Office is 30 HEDDON COURT, COCKFOSTERS ROAD, LONDON, EN4 0DF.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective January 2015).
2.2. Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 25%
2.4. Taxation
The charge for taxation takes into account taxation deferred as a result of timing differences between the treatment of certain items for taxation and accounting purposes. In general, deferred taxation is recognised in respect of timing differences that have originated but not reversed at the balance sheet date. However, deferred tax assets are recognised only to the extent that the directors consider that it is more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted. Deferred taxation is measured on a non-discounted basis at the tax rates that are expected to apply in periods in which the timing differences reverse, based on tax rates and the law enacted or substantively enacted at the balance sheet date.
2.5. Registrar Filing Requirements
The company has taken advantage of Companies Act 2006 section 444(1) and opted not to file the profit and loss account, directors report, and notes to the financial statements relating to the profit and loss account.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Tangible Assets
Computer Equipment
£
Cost
As at 1 April 2024 4,384
Disposals (4,384 )
As at 31 March 2025 -
Depreciation
As at 1 April 2024 3,032
Disposals (3,032 )
As at 31 March 2025 -
Net Book Value
As at 31 March 2025 -
As at 1 April 2024 1,352
Page 2
Page 3
5. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors 1 (1 )
Corporation tax 2,227 2,168
Accruals & deferred income (Current liabilities - creditors < 1 year) 1,450 1,200
Directors' loan accounts 467 114
4,145 3,481
6. Share Capital
2025 2024
Allotted, called up and fully paid £ £
2 Ordinary Shares of £ 1.000 each 2 2
7. Directors Advances, Credits and Guarantees
Dividends paid to directors
8. Dividends
2025 2024
£ £
On equity shares:
Final dividend paid 2,000 2,000
9. Ultimate Controlling Party
The company's ultimate controlling party is Dr Onyemaechi Abazie by virtue of his ownership of 100% of the issued share capital in the company.
Page 3